病症:卡尔莫杜林调节过化及其转化为疾病特异性聚合物
1Department of Biology, University of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada.
Biomolecules
|August 28, 2025
概括
病症涉及异常的蛋白聚合物,并与失调有关. 针对激活的卡尔莫杜林通路为这些神经退行性疾病提供新的治疗策略.
科学领域:
- 神经科学
- 生物化学
- 病理学
背景情况:
- 病是一种由含物定义的神经退行性疾病.
- 除了阿尔茨海默病的神经纤维状结之外,多种多样的陶聚合物是陶病的特征.
- 酸化和高酸化是所有酸化症的核心.
研究的目的:
- 审查失调和卡尔莫杜林 (CaM) 在病中的作用.
- 探索CaM介导的酸化和聚合途径.
- 确定CaM作为治疗病的目标.
主要方法:
- 文献审查侧重于信号传递,卡尔莫杜林和病理学.
- 参与酸化的CaM依赖性酶和酸酶的分析.
- 检查CaM在Tau聚合中的作用.
主要成果:
- 失调是病的早期激活事件.
- CaM 调节参与酸化的关键酶和酸酶.
- CaM与tau聚合有关,这是tau病的标志.
结论:
- 卡尔莫杜林在病的发病过程中起着重要作用.
- 针对 CaM 调节的途径提供了新的治疗途径.
- 抑制特定的CaM调节的Tau激酶是一种潜在的治疗策略.
相关概念视频
Calmodulin-dependent Signaling
5.3K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.3K
Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K
Phosphorylation
51.1K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
51.1K
Microtubule Associated Proteins (MAPs)
4.5K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.5K
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666


